Drug Type Small molecule drug |
Synonyms Triamcinolone diacetate (JAN/USP), NSC-13397, Aristocort + [1] |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization Fosun Pharma USA, Inc.Startup |
Drug Highest PhaseWithdrawn |
First Approval Date US (12 Mar 1959), |
Regulation- |
Molecular FormulaC25H31FO8 |
InChIKeyXGMPVBXKDAHORN-RBWIMXSLSA-N |
CAS Registry67-78-7 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anaphylaxis | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Endocrine System Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Eye Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Gastrointestinal Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Hematologic Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Kidney Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Leukemia | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Lymphoma | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Nervous System Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Respiratory Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Rheumatic Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |
Skin Diseases | US | Fosun Pharma USA, Inc.Startup | 12 Mar 1959 |